Franklin Resources
ODT

Franklin Resources’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Franklin Resources’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,007
Closed -$269K – 1971
2020
Q3 		$269K Sell
20,007
-1,045,175
-98% -$29.6M ﹤0.01% 1599
2020
Q2 		$41.4M Sell
1,065,182
-95,750
-8% -$3.1M 0.02% 583
2020
Q1 		$32.1M Sell
1,160,932
-29,026
-2% -$846K 0.02% 566
2019
Q4 		$38.6M Sell
1,189,958
-59,245
-5% -$1.84M 0.02% 601
2019
Q3 		$32.5M Sell
1,249,203
-238,433
-16% -$7.98M 0.02% 630
2019
Q2 		$54.6M Sell
1,487,636
-75,359
-5% -$1.81M 0.03% 529
2019
Q1 		$34.6M Sell
1,562,995
-38,218
-2% -$668K 0.02% 609
2018
Q4 		$22.5M Sell
1,601,213
-573
-0% -$8.92K 0.01% 677
2018
Q3 		$31.1M Sell
1,601,786
-232
-0% -$4.73K 0.02% 659
2018
Q2 		$35.4M Buy
1,602,018
+23,591
+1% +$550K 0.02% 620
2018
Q1 		$32.8M Buy
1,578,427
+500
+0% +$11.8K 0.02% 649
2017
Q4 		$38.4M Buy
+1,577,927
New +$37.3M 0.02% 604

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Franklin Resources's ODT Position: Q4 2020 in Review

Franklin Resources sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2020, closing a stake of 20,007 shares — an estimated $269K sold.

Franklin Resources first reported a position in ODT in Q4 2017 and held it in 12 quarters. The position peaked at $54.6M in Q2 2019. 94 funds tracked by Wall St. Rank hold ODT as of Q4 2020.

  • Franklin Resources reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Franklin Resources sold 20,007 Odonate Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $269K.
  • Franklin Resources first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
  • Franklin Resources's Odonate Therapeutics, Inc. Common Stock position peaked at $54.6M in Q2 2019.
  • 94 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Franklin Resources's 13F filing for Q4 2020, filed 10 Feb 2021.